312 related articles for article (PubMed ID: 26293548)
1. Injectable shear-thinning hydrogels used to deliver endothelial progenitor cells, enhance cell engraftment, and improve ischemic myocardium.
Gaffey AC; Chen MH; Venkataraman CM; Trubelja A; Rodell CB; Dinh PV; Hung G; MacArthur JW; Soopan RV; Burdick JA; Atluri P
J Thorac Cardiovasc Surg; 2015 Nov; 150(5):1268-76. PubMed ID: 26293548
[TBL] [Abstract][Full Text] [Related]
2. Delivery of progenitor cells with injectable shear-thinning hydrogel maintains geometry and normalizes strain to stabilize cardiac function after ischemia.
Gaffey AC; Chen MH; Trubelja A; Venkataraman CM; Chen CW; Chung JJ; Schultz S; Sehgal CM; Burdick JA; Atluri P
J Thorac Cardiovasc Surg; 2019 Apr; 157(4):1479-1490. PubMed ID: 30579534
[TBL] [Abstract][Full Text] [Related]
3. Sustained release of endothelial progenitor cell-derived extracellular vesicles from shear-thinning hydrogels improves angiogenesis and promotes function after myocardial infarction.
Chen CW; Wang LL; Zaman S; Gordon J; Arisi MF; Venkataraman CM; Chung JJ; Hung G; Gaffey AC; Spruce LA; Fazelinia H; Gorman RC; Seeholzer SH; Burdick JA; Atluri P
Cardiovasc Res; 2018 Jun; 114(7):1029-1040. PubMed ID: 29566124
[TBL] [Abstract][Full Text] [Related]
4. Delayed delivery of endothelial progenitor cell-derived extracellular vesicles via shear thinning gel improves postinfarct hemodynamics.
Chung JJ; Han J; Wang LL; Arisi MF; Zaman S; Gordon J; Li E; Kim ST; Tran Z; Chen CW; Gaffey AC; Burdick JA; Atluri P
J Thorac Cardiovasc Surg; 2020 May; 159(5):1825-1835.e2. PubMed ID: 31353103
[TBL] [Abstract][Full Text] [Related]
5. Tissue-engineered, hydrogel-based endothelial progenitor cell therapy robustly revascularizes ischemic myocardium and preserves ventricular function.
Atluri P; Miller JS; Emery RJ; Hung G; Trubelja A; Cohen JE; Lloyd K; Han J; Gaffey AC; MacArthur JW; Chen CS; Woo YJ
J Thorac Cardiovasc Surg; 2014 Sep; 148(3):1090-7; discussion 1097-8. PubMed ID: 25129603
[TBL] [Abstract][Full Text] [Related]
6. Alignment of inducible vascular progenitor cells on a micro-bundle scaffold improves cardiac repair following myocardial infarction.
Jamaiyar A; Wan W; Ohanyan V; Enrick M; Janota D; Cumpston D; Song H; Stevanov K; Kolz CL; Hakobyan T; Dong F; Newby BZ; Chilian WM; Yin L
Basic Res Cardiol; 2017 Jul; 112(4):41. PubMed ID: 28540527
[TBL] [Abstract][Full Text] [Related]
7. Injectable Shear-Thinning Hydrogels for Minimally Invasive Delivery to Infarcted Myocardium to Limit Left Ventricular Remodeling.
Rodell CB; Lee ME; Wang H; Takebayashi S; Takayama T; Kawamura T; Arkles JS; Dusaj NN; Dorsey SM; Witschey WR; Pilla JJ; Gorman JH; Wenk JF; Burdick JA; Gorman RC
Circ Cardiovasc Interv; 2016 Oct; 9(10):. PubMed ID: 27729419
[TBL] [Abstract][Full Text] [Related]
8. Endothelial progenitor cells delivered into the pericardial space incorporate into areas of ischemic myocardium.
Saltzman AJ; Choi SW; Dabreo A; Baur WE; Weiss E; Nguyen K; Ishibashi F; Celestin FF; Karia DH; Pandian NG; Karas RH; Waxman S
Cardiovasc Revasc Med; 2010; 11(4):241-8. PubMed ID: 20934657
[TBL] [Abstract][Full Text] [Related]
9. Erythropoietin improves the efficiency of endothelial progenitor cell therapy after myocardial infarction in mice: effects on transplanted cell survival and autologous endothelial progenitor cell mobilization.
Cheng Y; Hu R; Lv L; Ling L; Jiang S
J Surg Res; 2012 Jul; 176(1):e47-55. PubMed ID: 22595018
[TBL] [Abstract][Full Text] [Related]
10. Improvement of cardiac stem cell sheet therapy for chronic ischemic injury by adding endothelial progenitor cell transplantation: analysis of layer-specific regional cardiac function.
Kamata S; Miyagawa S; Fukushima S; Nakatani S; Kawamoto A; Saito A; Harada A; Shimizu T; Daimon T; Okano T; Asahara T; Sawa Y
Cell Transplant; 2014; 23(10):1305-19. PubMed ID: 23562134
[TBL] [Abstract][Full Text] [Related]
11. Layered smooth muscle cell-endothelial progenitor cell sheets derived from the bone marrow augment postinfarction ventricular function.
Shudo Y; Goldstone AB; Cohen JE; Patel JB; Hopkins MS; Steele AN; Edwards BB; Kawamura M; Miyagawa S; Sawa Y; Woo YJ
J Thorac Cardiovasc Surg; 2017 Sep; 154(3):955-963. PubMed ID: 28651946
[TBL] [Abstract][Full Text] [Related]
12. Genetic modification of mesenchymal stem cells overexpressing CCR1 increases cell viability, migration, engraftment, and capillary density in the injured myocardium.
Huang J; Zhang Z; Guo J; Ni A; Deb A; Zhang L; Mirotsou M; Pratt RE; Dzau VJ
Circ Res; 2010 Jun; 106(11):1753-62. PubMed ID: 20378860
[TBL] [Abstract][Full Text] [Related]
13. Neovasculogenic therapy to augment perfusion and preserve viability in ischemic cardiomyopathy.
Atluri P; Liao GP; Panlilio CM; Hsu VM; Leskowitz MJ; Morine KJ; Cohen JE; Berry MF; Suarez EE; Murphy DA; Lee WM; Gardner TJ; Sweeney HL; Woo YJ
Ann Thorac Surg; 2006 May; 81(5):1728-36. PubMed ID: 16631663
[TBL] [Abstract][Full Text] [Related]
14. Injection of autologous bone marrow cells in hyaluronan hydrogel improves cardiac performance after infarction in pigs.
Chen CH; Chang MY; Wang SS; Hsieh PC
Am J Physiol Heart Circ Physiol; 2014 Apr; 306(7):H1078-86. PubMed ID: 24508641
[TBL] [Abstract][Full Text] [Related]
15. Sustained release of engineered stromal cell-derived factor 1-α from injectable hydrogels effectively recruits endothelial progenitor cells and preserves ventricular function after myocardial infarction.
MacArthur JW; Purcell BP; Shudo Y; Cohen JE; Fairman A; Trubelja A; Patel J; Hsiao P; Yang E; Lloyd K; Hiesinger W; Atluri P; Burdick JA; Woo YJ
Circulation; 2013 Sep; 128(11 Suppl 1):S79-86. PubMed ID: 24030424
[TBL] [Abstract][Full Text] [Related]
16. Multi-phase catheter-injectable hydrogel enables dual-stage protein-engineered cytokine release to mitigate adverse left ventricular remodeling following myocardial infarction in a small animal model and a large animal model.
Steele AN; Paulsen MJ; Wang H; Stapleton LM; Lucian HJ; Eskandari A; Hironaka CE; Farry JM; Baker SW; Thakore AD; Jaatinen KJ; Tada Y; Hollander MJ; Williams KM; Seymour AJ; Totherow KP; Yu AC; Cochran JR; Appel EA; Woo YJ
Cytokine; 2020 Mar; 127():154974. PubMed ID: 31978642
[TBL] [Abstract][Full Text] [Related]
17. Hyaluronic acid-based hydrogel induces neovascularization and improves cardiac function in a rat model of myocardial infarction.
Abdalla S; Makhoul G; Duong M; Chiu RC; Cecere R
Interact Cardiovasc Thorac Surg; 2013 Nov; 17(5):767-72. PubMed ID: 23851989
[TBL] [Abstract][Full Text] [Related]
18. Stromal cell-derived factor and granulocyte-monocyte colony-stimulating factor form a combined neovasculogenic therapy for ischemic cardiomyopathy.
Woo YJ; Grand TJ; Berry MF; Atluri P; Moise MA; Hsu VM; Cohen J; Fisher O; Burdick J; Taylor M; Zentko S; Liao G; Smith M; Kolakowski S; Jayasankar V; Gardner TJ; Sweeney HL
J Thorac Cardiovasc Surg; 2005 Aug; 130(2):321-9. PubMed ID: 16077394
[TBL] [Abstract][Full Text] [Related]
19. Targeted trapping of endogenous endothelial progenitor cells for myocardial ischemic injury repair through neutrophil-mediated SPIO nanoparticle-conjugated CD34 antibody delivery and imaging.
Sun R; Wang X; Nie Y; Hu A; Liu H; Zhang K; Zhang L; Wu Q; Li K; Liu C; Zhang H; Zheng B; Li H; Xu H; Xu R; Fu H; Dai L; Jin R; Guo Y
Acta Biomater; 2022 Jul; 146():421-433. PubMed ID: 35545187
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-10 deficiency impairs bone marrow-derived endothelial progenitor cell survival and function in ischemic myocardium.
Krishnamurthy P; Thal M; Verma S; Hoxha E; Lambers E; Ramirez V; Qin G; Losordo D; Kishore R
Circ Res; 2011 Nov; 109(11):1280-9. PubMed ID: 21959218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
